Skip to main content

Laura Costa Comellas

Institutions of which they are part

Predoctoral researcher
Therapeutics and Innovations in Neuropediatrics and other paediatric rare diseases
Vall Hebron Institut de Recerca

Laura Costa Comellas

Institutions of which they are part

Predoctoral researcher
Therapeutics and Innovations in Neuropediatrics and other paediatric rare diseases
Vall Hebron Institut de Recerca

Projects

RED ESPAÑOLA DE NEUROPATÍAS AUTOINMUNES - Spanish Partnership for Autoimmune Neuropathies (SPAiN)

IP: Arnau Llauradó Gayete
Collaborators: Josep Quer Sivila, Laura Costa Comellas
Funding agency: Instituto de Salud Carlos III
Funding: 480370
Reference: PMPER24/00018
Duration: 01/01/2025 - 31/12/2026

Distrofia muscular congénita tipo 1A: inhibición de la fibrosis y corrección mediante edición génica

IP: -
Collaborators: Laura Costa Comellas, Francina Munell Casadesus, Maria Pallares Masmitja, David Gómez Andrés, Rocío Piñera Moreno
Funding agency: Instituto de Salud Carlos III
Funding: 117370
Reference: PI22/01027
Duration: 01/01/2023 - 30/06/2027

Neurologia infantil

IP: Alfons Macaya Ruíz
Collaborators: Laia Ventura i Expósito, Belen Perez Dueñas, Laura Costa Comellas, Francina Munell Casadesus, Anna Marcé Grau, Miquel Raspall Chaure, Mireia Del Toro Riera, Julia Sala Coromina, Ana Felipe Rucián, Neurologia infantil, David Gómez Andrés, Amaia Lasa Aranzasti, Lucy Dougherty de Miguel
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 0.01
Reference: 2021 SGR 01171
Duration: 01/01/2022 - 30/06/2025

Mejora del rendimiento diagnóstico en genes sarcoméricos de gran tamaño

IP: Francina Munell Casadesus
Collaborators: Laura Costa Comellas, Elena Antima Martinez Saez, Maite Avilés García, David Gómez Andrés
Funding agency: Instituto de Salud Carlos III
Funding: 73205
Reference: AC19/00048
Duration: 01/01/2020 - 31/12/2023

Related news

The project’s 4th annual meeting was recently held as part of the Fortalece–Salud programme of the Carlos III Health Institute.

Over the course of one week, it will host in-person assessments for 35 families to better understand the progression of the disease and contribute to the development of new therapies.

The event focused on advances in disease-modifying therapies and on the value of alliances between patients and professionals to promote more participatory care and research.

Related professionals

Richard Mast

Richard Mast

Research assistant
Biomedical Research in Urology
Read more
Eva Polverino

Eva Polverino

Main researcher
Pneumology
Read more
Maria Nazarena Pizzi

Maria Nazarena Pizzi

Senior researcher
Cardiovascular Diseases
Read more
Danilo Rivas Nicolls

Danilo Rivas Nicolls

Predoctoral researcher
Donation and transplantation of organs, tissues and cells
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.